Medacta Expands its Hip and Shoulder Portfolio

By Julie A. Vetalice

Medacta Expands its Hip and Shoulder Portfolio

Medacta received FDA 510(k) clearances for the M-Vizion Femoral Revision System Extension for hip replacement and the Long Humeral Diaphysis for shoulder joint replacement.

M-Vizion is designed for cementless use in total or partial hip arthroplasty in primary or revision surgery. The revision hip adds a broader range of options to the M-Vizion Modular Stem.

The Long Humeral Diaphysis is indicated for shoulder replacement in complex cases or when extended distal fixation is needed. The implant, available in two lengths, further expands the Medacta Shoulder System offering (pictured above) which includes a range of range of short, standard and long stems. The Long Humeral Diaphysis will be introduced into the market in selected centers through Medacta's M.O.R.E. Excellence Clinical Program.

"Medacta is constantly looking to expand our product offerings to better respond to patient needs. With our products we want to make surgeons more confident in the operating room and contribute to an enhanced patient experience," said Francesco Siccardi, CEO of Medacta. "As we continue to expand our product portfolio, we are committed to delivering solutions that can help optimize surgery, while minimizing recovery time and maximizing implant longevity."

Tags: 510(k) Clearance, Regulatory